Should add that while early July is not a required release date for results (audited figures arrive in August), the company has released unaudited results in early July every year for as long as I can go back. Either way, they're coming soon! Someone also mentioned they reached out to the company and got confirmation, and the posters here are usually more reliable than posters in other forums!
- Forums
- ASX - By Stock
- EYE
- POTENTIAL RE-RATE CATALYST EVENT: RESULTS
EYE
nova eye medical limited
Add to My Watchlist
4.17%
!
12.5¢

POTENTIAL RE-RATE CATALYST EVENT: RESULTS
-
-
-
Share
I agree that confirmation of sustained growth is very important. I am reminded of a post you made last year, highlighting this with a comparison of EYE to PNV. In the case of PNV the market was also slow to react to the strong growth being recorded, with the re-rate only occurring after they had recorded a full year of very strong growth. EYE is now at a similar stage to where PNV's rerate began.
https://hotcopper.com.au/threads/eye-pnv-comparison.7600559/
Looking forward to seeing what others have to share
- There are more pages in this discussion • 65 more messages in this thread...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $35.51M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $70.91K | 584.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 22056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 0.120 |
6 | 427932 | 0.115 |
5 | 671828 | 0.110 |
6 | 223371 | 0.105 |
6 | 295150 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 18584 | 1 |
0.130 | 104745 | 2 |
0.135 | 366584 | 3 |
0.140 | 346515 | 3 |
0.150 | 6000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online